| Symbol |
Name |
Standardized Value |
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
3.58
|
|
CD34
|
CD34 molecule
|
3.399
|
|
CAMTA1
|
calmodulin binding transcription activator 1
|
3.034
|
|
WWTR1
|
WW domain containing transcription regulator 1
|
2.731
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
2.662
|
|
TP53
|
tumor protein p53
|
2.644
|
|
KDR
|
kinase insert domain receptor
|
2.62
|
|
PTPRB
|
protein tyrosine phosphatase, receptor type, B
|
2.568
|
|
FLT4
|
fms-related tyrosine kinase 4
|
2.546
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
2.536
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
2.413
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
2.411
|
|
PLCG1
|
phospholipase C, gamma 1
|
2.394
|
|
VWF
|
von Willebrand factor
|
2.388
|
|
KRT7
|
keratin 7, type II
|
2.387
|
|
PDPN
|
podoplanin
|
2.364
|
|
MYOG
|
myogenin (myogenic factor 4)
|
2.363
|
|
CD68
|
CD68 molecule
|
2.362
|
|
CALB2
|
calbindin 2
|
2.341
|
|
CD99
|
CD99 molecule
|
2.331
|
|
EWSR1
|
EWS RNA-binding protein 1
|
2.317
|
|
CD99L2
|
CD99 molecule-like 2
|
2.317
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
2.294
|
|
F8
|
coagulation factor VIII, procoagulant component
|
2.254
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
2.248
|
|
CD274
|
CD274 molecule
|
2.233
|
|
CALD1
|
caldesmon 1
|
2.228
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
2.218
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
2.177
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
2.176
|
|
FLT1
|
fms-related tyrosine kinase 1
|
2.165
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
2.164
|
|
WT1
|
Wilms tumor 1
|
2.163
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
2.158
|
|
KRT5
|
keratin 5, type II
|
2.154
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
2.143
|
|
SSX2
|
synovial sarcoma, X breakpoint 2
|
2.143
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
2.122
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
2.119
|
|
NF1
|
neurofibromin 1
|
2.118
|
|
POT1
|
protection of telomeres 1
|
2.113
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
2.109
|
|
CDK4
|
cyclin-dependent kinase 4
|
2.08
|
|
AFP
|
alpha-fetoprotein
|
2.077
|
|
KRT20
|
keratin 20, type I
|
2.072
|
|
LEUTX
|
leucine twenty homeobox
|
2.051
|
|
SYP
|
synaptophysin
|
2.048
|
|
CD8A
|
CD8a molecule
|
2.041
|
|
MYOD1
|
myogenic differentiation 1
|
2.039
|
|
TIE1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
|
2.036
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
2.036
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
2.032
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
2.027
|
|
PTEN
|
phosphatase and tensin homolog
|
2.021
|
|
SSX1
|
synovial sarcoma, X breakpoint 1
|
2.02
|
|
YAP1
|
Yes-associated protein 1
|
2.018
|
|
PROX1
|
prospero homeobox 1
|
2.018
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
2.01
|
|
GNA14
|
guanine nucleotide binding protein (G protein), alpha 14
|
1.999
|
|
SLC43A3
|
solute carrier family 43, member 3
|
1.986
|
|
EGFR
|
epidermal growth factor receptor
|
1.983
|
|
TLE1
|
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)
|
1.983
|
|
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B
|
1.983
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
1.968
|
|
MME
|
membrane metallo-endopeptidase
|
1.966
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
1.954
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
1.951
|
|
IL2
|
interleukin 2
|
1.943
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
1.943
|
|
CEP85L
|
centrosomal protein 85kDa-like
|
1.939
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
1.937
|
|
ENG
|
endoglin
|
1.921
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
1.92
|
|
NUP160
|
nucleoporin 160kDa
|
1.914
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
1.913
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
1.908
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
1.897
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
1.896
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
1.883
|
|
KRT8
|
keratin 8, type II
|
1.876
|
|
PAX3
|
paired box 3
|
1.867
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
1.866
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
1.855
|
|
PAX8
|
paired box 8
|
1.849
|
|
GOPC
|
golgi-associated PDZ and coiled-coil motif containing
|
1.845
|
|
BRCA1
|
breast cancer 1, early onset
|
1.844
|
|
VEGFC
|
vascular endothelial growth factor C
|
1.84
|
|
BRCA2
|
breast cancer 2, early onset
|
1.826
|
|
ASPSCR1
|
alveolar soft part sarcoma chromosome region, candidate 1
|
1.823
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
1.821
|
|
DUX4
|
double homeobox 4
|
1.82
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
1.816
|
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1
|
1.815
|
|
CCND1
|
cyclin D1
|
1.814
|
|
SNRK
|
SNF related kinase
|
1.813
|
|
RET
|
ret proto-oncogene
|
1.809
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
1.808
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
1.799
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
1.797
|
|
PGR
|
progesterone receptor
|
1.797
|
|
NCAM1
|
neural cell adhesion molecule 1
|
1.791
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
1.79
|
|
TERT
|
telomerase reverse transcriptase
|
1.787
|
|
CD4
|
CD4 molecule
|
1.779
|
|
CD163
|
CD163 molecule
|
1.773
|
|
ESR1
|
estrogen receptor 1
|
1.77
|
|
PDCD1
|
programmed cell death 1
|
1.766
|
|
NUTM2A
|
NUT family member 2A
|
1.761
|
|
SS18
|
synovial sarcoma translocation, chromosome 18
|
1.749
|
|
FUS
|
FUS RNA binding protein
|
1.747
|
|
NAB2
|
NGFI-A binding protein 2 (EGR1 binding protein 2)
|
1.744
|
|
SFRP2
|
secreted frizzled-related protein 2
|
1.741
|
|
ALB
|
albumin
|
1.734
|
|
TSC2
|
tuberous sclerosis 2
|
1.729
|
|
FOXO1
|
forkhead box O1
|
1.729
|
|
KRT19
|
keratin 19, type I
|
1.726
|
|
PXDNL
|
peroxidasin-like
|
1.718
|
|
PXDN
|
peroxidasin
|
1.717
|
|
CTAG1B
|
cancer/testis antigen 1B
|
1.716
|
|
NUTM2B
|
NUT family member 2B
|
1.714
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
1.695
|
|
GPC3
|
glypican 3
|
1.694
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
1.689
|
|
TGFB1
|
transforming growth factor, beta 1
|
1.677
|
|
CHGA
|
chromogranin A
|
1.672
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
1.643
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
1.641
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
1.637
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
1.634
|
|
SSX2B
|
synovial sarcoma, X breakpoint 2B
|
1.631
|
|
ATM
|
ATM serine/threonine kinase
|
1.631
|
|
KRT18
|
keratin 18, type I
|
1.629
|
|
PHC2
|
polyhomeotic homolog 2 (Drosophila)
|
1.624
|
|
IFNA2
|
interferon, alpha 2
|
1.62
|
|
NUTM1
|
NUT midline carcinoma, family member 1
|
1.615
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
1.61
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
1.609
|
|
VEGFD
|
vascular endothelial growth factor D
|
1.606
|
|
TG
|
thyroglobulin
|
1.604
|
|
IL6
|
interleukin 6
|
1.604
|
|
EGF
|
epidermal growth factor
|
1.602
|
|
CCNB3
|
cyclin B3
|
1.598
|
|
NOTCH1
|
notch 1
|
1.597
|
|
NKX2-1
|
NK2 homeobox 1
|
1.594
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
1.585
|
|
ANGPT2
|
angiopoietin 2
|
1.583
|
|
MITF
|
microphthalmia-associated transcription factor
|
1.581
|
|
PAX7
|
paired box 7
|
1.58
|
|
IFNA1
|
interferon, alpha 1
|
1.58
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
1.579
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
1.574
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
1.571
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
1.57
|
|
GATA3
|
GATA binding protein 3
|
1.568
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
1.565
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
1.56
|
|
IFNA7
|
interferon, alpha 7
|
1.558
|
|
MMP9
|
matrix metallopeptidase 9
|
1.554
|
|
IFNA16
|
interferon, alpha 16
|
1.553
|
|
IFNA14
|
interferon, alpha 14
|
1.553
|
|
IFNA10
|
interferon, alpha 10
|
1.553
|
|
IFNA21
|
interferon, alpha 21
|
1.552
|
|
IFNA8
|
interferon, alpha 8
|
1.552
|
|
IFNA6
|
interferon, alpha 6
|
1.552
|
|
IFNA5
|
interferon, alpha 5
|
1.551
|
|
IFNA13
|
interferon, alpha 13
|
1.55
|
|
F2
|
coagulation factor II (thrombin)
|
1.547
|
|
IFNA4
|
interferon, alpha 4
|
1.547
|
|
SLC34A2
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 2
|
1.546
|
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
|
1.543
|
|
IFNA17
|
interferon, alpha 17
|
1.533
|
|
CRP
|
C-reactive protein, pentraxin-related
|
1.529
|
|
ACTB
|
actin, beta
|
1.529
|
|
IFNG
|
interferon, gamma
|
1.525
|
|
FGF4
|
fibroblast growth factor 4
|
1.521
|
|
SALL4
|
spalt-like transcription factor 4
|
1.519
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
1.519
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
1.518
|
|
YWHAE
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon
|
1.514
|
|
NFATC3
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3
|
1.51
|
|
KDELR2
|
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2
|
1.503
|
|
FGF3
|
fibroblast growth factor 3
|
1.503
|
|
VIM
|
vimentin
|
1.501
|
|
NF2
|
neurofibromin 2 (merlin)
|
1.498
|
|
FGF6
|
fibroblast growth factor 6
|
1.497
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
1.492
|
|
TNF
|
tumor necrosis factor
|
1.491
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
1.489
|
|
ANGPT1
|
angiopoietin 1
|
1.483
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
1.481
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
1.478
|
|
TINF2
|
TERF1 (TRF1)-interacting nuclear factor 2
|
1.477
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
1.476
|
|
ETV6
|
ets variant 6
|
1.474
|
|
FGF22
|
fibroblast growth factor 22
|
1.473
|
|
TERF1
|
telomeric repeat binding factor (NIMA-interacting) 1
|
1.471
|
|
FGF18
|
fibroblast growth factor 18
|
1.469
|
|
FGF10
|
fibroblast growth factor 10
|
1.469
|
|
KITLG
|
KIT ligand
|
1.468
|
|
FOXP3
|
forkhead box P3
|
1.464
|
|
CDK6
|
cyclin-dependent kinase 6
|
1.464
|
|
FGF16
|
fibroblast growth factor 16
|
1.461
|
|
MCAM
|
melanoma cell adhesion molecule
|
1.459
|
|
FGF20
|
fibroblast growth factor 20
|
1.459
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
1.458
|
|
ETV4
|
ets variant 4
|
1.458
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
1.456
|
|
ETV1
|
ets variant 1
|
1.454
|
|
DAXX
|
death-domain associated protein
|
1.454
|
|
LRIG3
|
leucine-rich repeats and immunoglobulin-like domains 3
|
1.454
|
|
FGF5
|
fibroblast growth factor 5
|
1.453
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
1.453
|
|
FGF17
|
fibroblast growth factor 17
|
1.451
|
|
FGF7
|
fibroblast growth factor 7
|
1.45
|
|
MAGEA4
|
melanoma antigen family A4
|
1.449
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
1.44
|
|
FGF9
|
fibroblast growth factor 9
|
1.439
|
|
HMGA2
|
high mobility group AT-hook 2
|
1.438
|
|
SATB2
|
SATB homeobox 2
|
1.437
|
|
TP63
|
tumor protein p63
|
1.434
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
1.428
|
|
PCNA
|
proliferating cell nuclear antigen
|
1.427
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
1.423
|
|
MB
|
myoglobin
|
1.422
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
1.421
|
|
CDX2
|
caudal type homeobox 2
|
1.418
|
|
SSX4B
|
synovial sarcoma, X breakpoint 4B
|
1.417
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
1.414
|
|
DICER1
|
dicer 1, ribonuclease type III
|
1.412
|
|
SSX4
|
synovial sarcoma, X breakpoint 4
|
1.411
|
|
TPM3
|
tropomyosin 3
|
1.411
|
|
CLDN5
|
claudin 5
|
1.408
|
|
FN1
|
fibronectin 1
|
1.405
|
|
THBS1
|
thrombospondin 1
|
1.405
|
|
GFAP
|
glial fibrillary acidic protein
|
1.398
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
1.397
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
1.397
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
1.395
|
|
EPCAM
|
epithelial cell adhesion molecule
|
1.394
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
1.393
|
|
NCOA2
|
nuclear receptor coactivator 2
|
1.391
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
1.389
|
|
THBD
|
thrombomodulin
|
1.387
|
|
CD44
|
CD44 molecule (Indian blood group)
|
1.384
|
|
PGF
|
placental growth factor
|
1.384
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
1.38
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
1.377
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
1.375
|
|
MUC1
|
mucin 1, cell surface associated
|
1.368
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
1.364
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
1.364
|
|
MSH6
|
mutS homolog 6
|
1.362
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
1.361
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
1.358
|
|
JUN
|
jun proto-oncogene
|
1.355
|
|
NAPSA
|
napsin A aspartic peptidase
|
1.354
|
|
COL1A1
|
collagen, type I, alpha 1
|
1.354
|
|
CDH17
|
cadherin 17, LI cadherin (liver-intestine)
|
1.35
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
1.346
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
1.346
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
1.341
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
1.34
|
|
NES
|
nestin
|
1.339
|
|
CD1E
|
CD1e molecule
|
1.339
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
1.339
|
|
CHEK2
|
checkpoint kinase 2
|
1.336
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
1.334
|
|
CD1A
|
CD1a molecule
|
1.329
|
|
CD5
|
CD5 molecule
|
1.326
|
|
FOXO4
|
forkhead box O4
|
1.321
|
|
PAX5
|
paired box 5
|
1.321
|
|
CD1B
|
CD1b molecule
|
1.321
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
1.317
|
|
MTAP
|
methylthioadenosine phosphorylase
|
1.316
|
|
FLT3
|
fms-related tyrosine kinase 3
|
1.315
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
1.315
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
1.314
|
|
NOTCH2
|
notch 2
|
1.313
|
|
PLAU
|
plasminogen activator, urokinase
|
1.311
|
|
MMP2
|
matrix metallopeptidase 2
|
1.309
|
|
ADRB1
|
adrenoceptor beta 1
|
1.308
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
1.308
|
|
ADRB3
|
adrenoceptor beta 3
|
1.307
|
|
PROM1
|
prominin 1
|
1.303
|
|
GID4
|
GID complex subunit 4
|
1.303
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
1.303
|
|
H3-3B
|
H3.3 histone B
|
1.301
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
1.3
|
|
NKX2-2
|
NK2 homeobox 2
|
1.299
|
|
ATF1
|
activating transcription factor 1
|
1.299
|
|
IL1B
|
interleukin 1, beta
|
1.291
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
1.286
|
|
TSC1
|
tuberous sclerosis 1
|
1.279
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
1.277
|
|
GJA4
|
gap junction protein, alpha 4, 37kDa
|
1.276
|
|
MUC4
|
mucin 4, cell surface associated
|
1.274
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
1.267
|
|
KRT14
|
keratin 14, type I
|
1.267
|
|
CD1C
|
CD1c molecule
|
1.26
|
|
TPD52L1
|
tumor protein D52-like 1
|
1.26
|
|
SDC4
|
syndecan 4
|
1.26
|
|
DLL4
|
delta-like 4 (Drosophila)
|
1.26
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
1.259
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
1.258
|
|
CDKN2AIP
|
CDKN2A interacting protein
|
1.257
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
1.255
|
|
CREB3L2
|
cAMP responsive element binding protein 3-like 2
|
1.252
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
1.252
|
|
H3C12
|
H3 clustered histone 12
|
1.251
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
1.245
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
1.245
|
|
MDM4
|
MDM4, p53 regulator
|
1.244
|
|
PTCH1
|
patched 1
|
1.238
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
1.237
|
|
SPN
|
sialophorin
|
1.237
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
1.236
|
|
MLH1
|
mutL homolog 1
|
1.234
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
1.231
|
|
IL10
|
interleukin 10
|
1.229
|
|
ICAM1
|
intercellular adhesion molecule 1
|
1.226
|
|
MSH2
|
mutS homolog 2
|
1.225
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
1.223
|
|
MED12
|
mediator complex subunit 12
|
1.221
|
|
VEGFB
|
vascular endothelial growth factor B
|
1.219
|
|
TK1
|
thymidine kinase 1, soluble
|
1.219
|
|
H3-4
|
H3.4 histone, cluster member
|
1.219
|
|
CCND2
|
cyclin D2
|
1.218
|
|
NR4A3
|
nuclear receptor subfamily 4, group A, member 3
|
1.217
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
1.214
|
|
H3C13
|
H3 clustered histone 13
|
1.213
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
1.213
|
|
CD1D
|
CD1d molecule
|
1.213
|
|
H3-5
|
H3.5 histone
|
1.213
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
1.212
|
|
SOX18
|
SRY (sex determining region Y)-box 18
|
1.212
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
1.211
|
|
HDAC9
|
histone deacetylase 9
|
1.207
|
|
SPP1
|
secreted phosphoprotein 1
|
1.202
|
|
CCDC6
|
coiled-coil domain containing 6
|
1.202
|
|
ANXA5
|
annexin A5
|
1.199
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
1.199
|
|
IGF2
|
insulin-like growth factor 2
|
1.197
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
1.194
|
|
ETV5
|
ets variant 5
|
1.192
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
1.192
|
|
BAX
|
BCL2-associated X protein
|
1.189
|
|
TERF2IP
|
telomeric repeat binding factor 2, interacting protein
|
1.186
|
|
INS
|
insulin
|
1.185
|
|
TCHP
|
trichoplein, keratin filament binding
|
1.184
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
1.184
|
|
TSPAN31
|
tetraspanin 31
|
1.181
|
|
VGLL2
|
vestigial-like family member 2
|
1.181
|
|
LAG3
|
lymphocyte-activation gene 3
|
1.18
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
1.18
|
|
CCDC27
|
coiled-coil domain containing 27
|
1.179
|
|
MYH14
|
myosin, heavy chain 14, non-muscle
|
1.174
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
1.173
|
|
SIRPA
|
signal-regulatory protein alpha
|
1.171
|
|
FAT1
|
FAT atypical cadherin 1
|
1.169
|
|
TYR
|
tyrosinase
|
1.166
|
|
BCL2L1
|
BCL2-like 1
|
1.166
|
|
MMP1
|
matrix metallopeptidase 1
|
1.165
|
|
GLI1
|
GLI family zinc finger 1
|
1.164
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
1.162
|
|
EPHA2
|
EPH receptor A2
|
1.162
|
|
SETD2
|
SET domain containing 2
|
1.16
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
1.16
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
1.158
|
|
EDN1
|
endothelin 1
|
1.158
|
|
GDF2
|
growth differentiation factor 2
|
1.156
|
|
TEAD1
|
TEA domain family member 1 (SV40 transcriptional enhancer factor)
|
1.155
|
|
MCL1
|
myeloid cell leukemia 1
|
1.154
|
|
POU5F1
|
POU class 5 homeobox 1
|
1.154
|
|
SIRT1
|
sirtuin 1
|
1.153
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
1.153
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
1.153
|
|
CD86
|
CD86 molecule
|
1.151
|
|
EZR
|
ezrin
|
1.148
|
|
CD47
|
CD47 molecule
|
1.145
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
1.144
|
|
CCNL2
|
cyclin L2
|
1.143
|
|
FRS2
|
fibroblast growth factor receptor substrate 2
|
1.143
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
1.142
|
|
SDC1
|
syndecan 1
|
1.142
|
|
PLG
|
plasminogen
|
1.141
|
|
CREB1
|
cAMP responsive element binding protein 1
|
1.14
|
|
KLK3
|
kallikrein-related peptidase 3
|
1.137
|
|
ACR
|
acrosin
|
1.135
|
|
RPS6KB2
|
ribosomal protein S6 kinase, 70kDa, polypeptide 2
|
1.134
|
|
OSCAR
|
osteoclast associated, immunoglobulin-like receptor
|
1.13
|
|
LIMA1
|
LIM domain and actin binding 1
|
1.129
|
|
ACD
|
adrenocortical dysplasia homolog (mouse)
|
1.129
|
|
ZC3H7B
|
zinc finger CCCH-type containing 7B
|
1.127
|
|
SNAI2
|
snail family zinc finger 2
|
1.125
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
1.125
|
|
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit
|
1.124
|
|
FANCA
|
Fanconi anemia, complementation group A
|
1.124
|
|
PIP
|
prolactin-induced protein
|
1.122
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
1.122
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
1.122
|
|
JAK2
|
Janus kinase 2
|
1.119
|
|
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
|
1.118
|
|
NUP37
|
nucleoporin 37kDa
|
1.114
|
|
CCN2
|
cellular communication network factor 2
|
1.114
|
|
AURKA
|
aurora kinase A
|
1.112
|
|
NUTM2E
|
NUT family member 2E
|
1.111
|
|
HEY1
|
hes-related family bHLH transcription factor with YRPW motif 1
|
1.111
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
1.11
|
|
FKBP1A
|
FK506 binding protein 1A, 12kDa
|
1.109
|
|
AXIN1
|
axin 1
|
1.104
|
|
CHEK1
|
checkpoint kinase 1
|
1.103
|
|
CD80
|
CD80 molecule
|
1.103
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
1.102
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
1.1
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
1.099
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
1.099
|
|
CLTC
|
clathrin, heavy chain (Hc)
|
1.098
|
|
TLE3
|
transducin-like enhancer of split 3
|
1.095
|
|
FGF13
|
fibroblast growth factor 13
|
1.092
|
|
AR
|
androgen receptor
|
1.092
|
|
CDK2
|
cyclin-dependent kinase 2
|
1.089
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
1.088
|
|
RHEB
|
Ras homolog enriched in brain
|
1.08
|
|
ALPP
|
alkaline phosphatase, placental
|
1.076
|
|
EFNA3
|
ephrin-A3
|
1.075
|
|
SHH
|
sonic hedgehog
|
1.069
|
|
IL1A
|
interleukin 1, alpha
|
1.068
|
|
CDKN2D
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)
|
1.067
|
|
FOXM1
|
forkhead box M1
|
1.066
|
|
CCNA1
|
cyclin A1
|
1.066
|
|
RAG2
|
recombination activating gene 2
|
1.065
|
|
IL4
|
interleukin 4
|
1.063
|
|
CD19
|
CD19 molecule
|
1.061
|
|
SMAD4
|
SMAD family member 4
|
1.06
|
|
UPK3A
|
uroplakin 3A
|
1.059
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
1.059
|
|
ARG1
|
arginase 1
|
1.059
|
|
RB1
|
retinoblastoma 1
|
1.058
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
1.058
|
|
PTK2
|
protein tyrosine kinase 2
|
1.057
|
|
LATS1
|
large tumor suppressor kinase 1
|
1.056
|
|
SNAI1
|
snail family zinc finger 1
|
1.056
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
1.055
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
1.055
|
|
ERCC6L
|
excision repair cross-complementation group 6-like
|
1.054
|
|
NANOG
|
Nanog homeobox
|
1.054
|
|
SIRT7
|
sirtuin 7
|
1.053
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
1.053
|
|
CCNA2
|
cyclin A2
|
1.052
|
|
RHOA
|
ras homolog family member A
|
1.05
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
1.049
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
1.047
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
1.045
|
|
PBRM1
|
polybromo 1
|
1.042
|
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
|
1.039
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
1.035
|
|
CCNE1
|
cyclin E1
|
1.034
|
|
PDGFC
|
platelet derived growth factor C
|
1.033
|
|
STK11
|
serine/threonine kinase 11
|
1.032
|
|
USP6
|
ubiquitin specific peptidase 6
|
1.032
|
|
BRD4
|
bromodomain containing 4
|
1.031
|
|
PALB2
|
partner and localizer of BRCA2
|
1.031
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
1.03
|
|
SHB
|
Src homology 2 domain containing adaptor protein B
|
1.029
|
|
TKFC
|
triokinase/FMN cyclase
|
1.029
|
|
KDM2B
|
lysine (K)-specific demethylase 2B
|
1.028
|
|
LOX
|
lysyl oxidase
|
1.027
|
|
ISLR2
|
immunoglobulin superfamily containing leucine-rich repeat 2
|
1.027
|
|
FOXO3
|
forkhead box O3
|
1.026
|
|
EPHB4
|
EPH receptor B4
|
1.025
|
|
CA9
|
carbonic anhydrase IX
|
1.023
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
1.021
|
|
ANTXR1
|
anthrax toxin receptor 1
|
1.02
|
|
E2F3
|
E2F transcription factor 3
|
1.019
|
|
POTEF
|
POTE ankyrin domain family, member F
|
1.019
|
|
CTC1
|
CTS telomere maintenance complex component 1
|
1.017
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
1.016
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
1.015
|
|
EXT1
|
exostosin glycosyltransferase 1
|
1.013
|
|
CD28
|
CD28 molecule
|
1.012
|
|
CYCS
|
cytochrome c, somatic
|
1.003
|
